4.5 |
13.6 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
3.9 |
11.7 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
2.8 |
2.8 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
2.6 |
41.8 |
GO:0021683 |
cerebellar granular layer morphogenesis(GO:0021683) |
2.4 |
7.1 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
2.3 |
6.9 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
2.2 |
6.7 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
2.2 |
6.6 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
2.1 |
6.4 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
2.0 |
5.9 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
1.9 |
7.6 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
1.9 |
5.7 |
GO:0090403 |
oxidative stress-induced premature senescence(GO:0090403) |
1.7 |
5.1 |
GO:1904049 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
1.6 |
1.6 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.4 |
4.3 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
1.4 |
7.1 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
1.4 |
1.4 |
GO:1903977 |
positive regulation of glial cell migration(GO:1903977) |
1.4 |
5.5 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
1.4 |
6.8 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
1.4 |
5.4 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
1.3 |
7.5 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
1.3 |
2.5 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
1.2 |
3.7 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
1.2 |
24.0 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
1.2 |
4.8 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
1.2 |
4.8 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
1.2 |
4.8 |
GO:0009414 |
response to water deprivation(GO:0009414) |
1.2 |
3.5 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
1.2 |
2.3 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
1.1 |
5.7 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.1 |
4.5 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
1.1 |
3.4 |
GO:1905049 |
negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
1.1 |
8.9 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.1 |
4.4 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
1.1 |
4.3 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
1.1 |
3.2 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
1.0 |
6.2 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
1.0 |
4.1 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
1.0 |
5.1 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
1.0 |
5.1 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.0 |
7.9 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
1.0 |
3.9 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
1.0 |
6.8 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
1.0 |
3.8 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
0.9 |
2.8 |
GO:1902044 |
regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
0.9 |
2.8 |
GO:0008228 |
opsonization(GO:0008228) |
0.9 |
1.9 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
0.9 |
2.8 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.9 |
2.8 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
0.9 |
2.7 |
GO:0060437 |
lung growth(GO:0060437) |
0.9 |
2.7 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
0.9 |
3.5 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
0.9 |
3.4 |
GO:0021586 |
pons maturation(GO:0021586) |
0.9 |
2.6 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
0.8 |
4.2 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.8 |
3.3 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.8 |
4.0 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.8 |
2.4 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
0.8 |
3.2 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.8 |
4.0 |
GO:2000587 |
regulation of phospholipase A2 activity(GO:0032429) regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.8 |
10.3 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.8 |
4.7 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
0.8 |
3.1 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
0.8 |
6.2 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
0.8 |
5.5 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
0.8 |
3.1 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.8 |
3.9 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.8 |
3.0 |
GO:0035624 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.8 |
2.3 |
GO:0009405 |
pathogenesis(GO:0009405) |
0.7 |
6.5 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.7 |
3.5 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
0.7 |
2.8 |
GO:0046469 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.7 |
2.8 |
GO:0007412 |
axon target recognition(GO:0007412) |
0.7 |
0.7 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.7 |
2.0 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
0.7 |
4.6 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
0.7 |
0.7 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.7 |
2.6 |
GO:1902837 |
lysine transport(GO:0015819) amino acid import into cell(GO:1902837) |
0.6 |
1.9 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
0.6 |
3.2 |
GO:1904721 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.6 |
1.3 |
GO:0008355 |
olfactory learning(GO:0008355) |
0.6 |
4.4 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
0.6 |
10.6 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.6 |
1.9 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.6 |
4.9 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
0.6 |
2.4 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
0.6 |
4.8 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
0.6 |
1.8 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
0.6 |
4.2 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
0.6 |
4.7 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
0.6 |
1.8 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
0.6 |
3.5 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.6 |
1.1 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
0.6 |
3.4 |
GO:0006172 |
ADP biosynthetic process(GO:0006172) |
0.6 |
2.2 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
0.6 |
9.0 |
GO:1901629 |
regulation of presynaptic membrane organization(GO:1901629) |
0.6 |
2.2 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
0.6 |
1.7 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
0.6 |
5.0 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
0.6 |
2.8 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.5 |
2.2 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.5 |
2.7 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.5 |
1.6 |
GO:0046878 |
regulation of saliva secretion(GO:0046877) positive regulation of saliva secretion(GO:0046878) |
0.5 |
1.0 |
GO:0086017 |
Purkinje myocyte action potential(GO:0086017) |
0.5 |
1.6 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
0.5 |
2.6 |
GO:0060161 |
positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.5 |
1.0 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
0.5 |
5.1 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
0.5 |
2.0 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
0.5 |
2.0 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
0.5 |
3.5 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.5 |
1.5 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
0.5 |
1.5 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
0.5 |
4.0 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
0.5 |
2.5 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.5 |
6.4 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.5 |
2.4 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
0.5 |
3.4 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
0.5 |
12.5 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.5 |
3.3 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.5 |
1.4 |
GO:0010046 |
response to mycotoxin(GO:0010046) |
0.5 |
1.4 |
GO:0021852 |
pyramidal neuron migration(GO:0021852) |
0.5 |
3.7 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
0.5 |
1.4 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.5 |
3.2 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
0.4 |
1.3 |
GO:0046959 |
habituation(GO:0046959) |
0.4 |
4.5 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.4 |
2.2 |
GO:0016266 |
O-glycan processing(GO:0016266) |
0.4 |
1.3 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.4 |
0.4 |
GO:0072393 |
microtubule anchoring at microtubule organizing center(GO:0072393) |
0.4 |
1.3 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
0.4 |
6.9 |
GO:0032060 |
bleb assembly(GO:0032060) |
0.4 |
1.3 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
0.4 |
3.4 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.4 |
3.4 |
GO:0060012 |
synaptic transmission, glycinergic(GO:0060012) |
0.4 |
1.2 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
0.4 |
2.9 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 |
1.2 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.4 |
2.0 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
0.4 |
2.7 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
0.4 |
4.7 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
0.4 |
1.6 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.4 |
1.9 |
GO:0051775 |
response to redox state(GO:0051775) |
0.4 |
1.9 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
0.4 |
2.3 |
GO:0002934 |
desmosome organization(GO:0002934) |
0.4 |
1.1 |
GO:0019346 |
homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.4 |
1.5 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.4 |
1.1 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
0.4 |
3.3 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
0.4 |
1.8 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
0.4 |
4.8 |
GO:0070842 |
aggresome assembly(GO:0070842) |
0.4 |
1.4 |
GO:0090218 |
positive regulation of lipid kinase activity(GO:0090218) |
0.4 |
1.1 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
0.4 |
2.9 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
0.4 |
4.2 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
0.3 |
5.6 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
0.3 |
3.1 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 |
0.7 |
GO:0071398 |
cellular response to fatty acid(GO:0071398) |
0.3 |
1.0 |
GO:0021546 |
rhombomere development(GO:0021546) |
0.3 |
1.0 |
GO:0030862 |
regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.3 |
2.0 |
GO:0043113 |
receptor clustering(GO:0043113) |
0.3 |
3.6 |
GO:0032793 |
positive regulation of CREB transcription factor activity(GO:0032793) |
0.3 |
1.3 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
0.3 |
1.3 |
GO:0015886 |
heme transport(GO:0015886) |
0.3 |
1.0 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
0.3 |
0.9 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.3 |
0.6 |
GO:0036394 |
amylase secretion(GO:0036394) |
0.3 |
0.6 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
0.3 |
3.8 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.3 |
1.3 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
0.3 |
2.2 |
GO:0060746 |
parental behavior(GO:0060746) |
0.3 |
3.7 |
GO:0009109 |
coenzyme catabolic process(GO:0009109) |
0.3 |
0.9 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
0.3 |
2.5 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.3 |
2.2 |
GO:0002591 |
positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.3 |
0.9 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.3 |
3.3 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.3 |
0.9 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
0.3 |
1.8 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 |
1.8 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
0.3 |
1.2 |
GO:1903347 |
cellular response to testosterone stimulus(GO:0071394) negative regulation of bicellular tight junction assembly(GO:1903347) |
0.3 |
2.6 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
0.3 |
0.6 |
GO:0035106 |
operant conditioning(GO:0035106) |
0.3 |
3.8 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
0.3 |
0.6 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
0.3 |
2.0 |
GO:0090331 |
negative regulation of platelet aggregation(GO:0090331) |
0.3 |
1.7 |
GO:2000973 |
regulation of pro-B cell differentiation(GO:2000973) |
0.3 |
6.6 |
GO:0001964 |
startle response(GO:0001964) |
0.3 |
1.2 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.3 |
1.4 |
GO:0006534 |
cysteine metabolic process(GO:0006534) |
0.3 |
0.3 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
0.3 |
2.0 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 |
1.7 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
0.3 |
0.3 |
GO:0035799 |
ureter maturation(GO:0035799) |
0.3 |
5.5 |
GO:0006491 |
N-glycan processing(GO:0006491) |
0.3 |
1.4 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
0.3 |
6.7 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.3 |
3.5 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
0.3 |
2.7 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
0.3 |
0.8 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
0.3 |
3.1 |
GO:0033008 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.3 |
1.0 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
0.3 |
0.8 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
0.3 |
0.8 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
0.3 |
2.3 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
0.3 |
2.3 |
GO:0071435 |
potassium ion export(GO:0071435) |
0.3 |
3.0 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.3 |
1.3 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
0.3 |
1.8 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 |
2.5 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 |
2.0 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
0.2 |
0.7 |
GO:2000813 |
actin filament uncapping(GO:0051695) negative regulation of barbed-end actin filament capping(GO:2000813) |
0.2 |
2.4 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
0.2 |
1.9 |
GO:0046519 |
sphingoid metabolic process(GO:0046519) |
0.2 |
1.0 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
0.2 |
1.4 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.2 |
4.7 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 |
2.1 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
0.2 |
0.9 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
0.2 |
0.5 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
0.2 |
3.7 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.2 |
1.8 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 |
0.9 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 |
0.2 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
0.2 |
0.9 |
GO:2000188 |
regulation of cholesterol homeostasis(GO:2000188) |
0.2 |
4.2 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
0.2 |
4.6 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 |
0.7 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) |
0.2 |
0.4 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
0.2 |
0.9 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
0.2 |
1.5 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
0.2 |
0.6 |
GO:0043201 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.2 |
4.6 |
GO:0008210 |
estrogen metabolic process(GO:0008210) |
0.2 |
0.8 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.2 |
0.8 |
GO:0099622 |
cardiac muscle cell membrane repolarization(GO:0099622) regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
0.2 |
5.2 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 |
0.8 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 |
1.4 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 |
1.6 |
GO:0055089 |
fatty acid homeostasis(GO:0055089) |
0.2 |
3.8 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
0.2 |
1.8 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.2 |
6.1 |
GO:1901381 |
positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.2 |
1.4 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
0.2 |
0.6 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
0.2 |
2.4 |
GO:0071625 |
vocalization behavior(GO:0071625) |
0.2 |
1.8 |
GO:0031339 |
negative regulation of vesicle fusion(GO:0031339) |
0.2 |
1.9 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 |
3.1 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
0.2 |
5.8 |
GO:0086001 |
cardiac muscle cell action potential(GO:0086001) |
0.2 |
0.6 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) transepithelial ammonium transport(GO:0070634) |
0.2 |
1.0 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.2 |
0.7 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.2 |
3.9 |
GO:0060074 |
synapse maturation(GO:0060074) |
0.2 |
0.9 |
GO:0021894 |
cerebral cortex GABAergic interneuron development(GO:0021894) |
0.2 |
1.3 |
GO:0006968 |
cellular defense response(GO:0006968) |
0.2 |
7.3 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.2 |
1.8 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.2 |
0.7 |
GO:0031033 |
myosin filament organization(GO:0031033) |
0.2 |
1.1 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
0.2 |
3.4 |
GO:0010039 |
response to iron ion(GO:0010039) |
0.2 |
0.7 |
GO:0090188 |
negative regulation of pancreatic juice secretion(GO:0090188) |
0.2 |
0.9 |
GO:0009268 |
response to pH(GO:0009268) |
0.2 |
1.4 |
GO:0055090 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.2 |
1.3 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
0.2 |
0.7 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 |
1.1 |
GO:0007296 |
vitellogenesis(GO:0007296) |
0.2 |
1.1 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 |
5.0 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
0.2 |
1.0 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
0.2 |
0.8 |
GO:0001927 |
exocyst assembly(GO:0001927) |
0.2 |
3.0 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
0.2 |
2.6 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
0.2 |
0.5 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
0.2 |
1.9 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
0.2 |
8.7 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
0.2 |
10.2 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 |
1.3 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
0.2 |
0.3 |
GO:0045869 |
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.2 |
1.1 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 |
3.0 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
0.1 |
2.2 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
0.1 |
0.9 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
0.1 |
1.2 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 |
0.4 |
GO:0097459 |
ferric iron import(GO:0033216) iron ion import into cell(GO:0097459) ferric iron import into cell(GO:0097461) |
0.1 |
1.9 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
0.1 |
2.7 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
0.1 |
2.4 |
GO:0031167 |
rRNA methylation(GO:0031167) |
0.1 |
2.9 |
GO:0033622 |
integrin activation(GO:0033622) |
0.1 |
1.1 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
0.1 |
8.9 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
0.1 |
2.6 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
0.1 |
0.4 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
0.1 |
0.4 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
0.1 |
0.4 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 |
1.1 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
0.1 |
2.7 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
0.1 |
0.4 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
0.1 |
1.8 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 |
0.5 |
GO:1901660 |
calcium ion export(GO:1901660) |
0.1 |
1.6 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
0.1 |
1.9 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
0.1 |
1.1 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 |
0.2 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
0.1 |
2.0 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 |
0.3 |
GO:0032916 |
transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
0.1 |
3.2 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
0.1 |
1.9 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 |
0.3 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
0.1 |
0.3 |
GO:0046541 |
saliva secretion(GO:0046541) |
0.1 |
2.1 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 |
0.8 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 |
1.0 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
0.1 |
1.0 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.1 |
1.4 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
0.1 |
1.6 |
GO:0002028 |
regulation of sodium ion transport(GO:0002028) |
0.1 |
0.5 |
GO:0071635 |
negative regulation of transforming growth factor beta1 production(GO:0032911) negative regulation of transforming growth factor beta production(GO:0071635) |
0.1 |
4.8 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 |
0.3 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 |
1.1 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 |
0.7 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
0.1 |
0.3 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 |
0.3 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
0.1 |
2.0 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 |
0.8 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
0.1 |
1.3 |
GO:0010960 |
magnesium ion homeostasis(GO:0010960) |
0.1 |
1.6 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
0.1 |
0.7 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 |
13.4 |
GO:0008654 |
phospholipid biosynthetic process(GO:0008654) |
0.1 |
1.3 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
0.1 |
1.6 |
GO:0048278 |
vesicle docking(GO:0048278) |
0.1 |
0.5 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
0.1 |
1.6 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
0.1 |
0.4 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.1 |
1.3 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 |
0.6 |
GO:0019985 |
translesion synthesis(GO:0019985) |
0.1 |
0.4 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.1 |
0.8 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 |
0.8 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
0.1 |
0.8 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
0.1 |
0.2 |
GO:0042448 |
progesterone metabolic process(GO:0042448) |
0.1 |
0.9 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
0.1 |
0.5 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 |
3.1 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
0.1 |
0.7 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
0.1 |
7.9 |
GO:0006906 |
vesicle fusion(GO:0006906) |
0.1 |
0.8 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 |
0.6 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
0.1 |
0.4 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 |
0.7 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
0.1 |
1.7 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
0.1 |
2.8 |
GO:0070206 |
protein trimerization(GO:0070206) |
0.1 |
0.7 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
0.1 |
3.1 |
GO:1902653 |
cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 |
1.0 |
GO:0002021 |
response to dietary excess(GO:0002021) |
0.1 |
4.6 |
GO:0035773 |
insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.1 |
1.2 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
0.1 |
3.4 |
GO:0015914 |
phospholipid transport(GO:0015914) |
0.1 |
0.8 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
0.1 |
0.9 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
0.1 |
1.3 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
0.1 |
1.9 |
GO:0048008 |
platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.1 |
1.6 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
0.1 |
0.2 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 |
0.3 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 |
0.4 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
0.1 |
0.4 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
0.1 |
0.4 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
0.1 |
0.3 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
0.1 |
1.3 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 |
1.4 |
GO:2001240 |
negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.1 |
1.7 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
0.1 |
0.4 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
0.1 |
3.5 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
0.1 |
0.3 |
GO:0051013 |
microtubule severing(GO:0051013) |
0.1 |
0.7 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
0.1 |
0.9 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
0.1 |
0.6 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
0.1 |
0.5 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 |
0.4 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
0.1 |
1.5 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
0.1 |
0.3 |
GO:2000301 |
negative regulation of synaptic vesicle transport(GO:1902804) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 |
0.2 |
GO:0060390 |
regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 |
0.7 |
GO:2000401 |
regulation of lymphocyte migration(GO:2000401) |
0.1 |
0.5 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
0.1 |
0.6 |
GO:0034243 |
regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.1 |
0.6 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 |
1.1 |
GO:0032456 |
endocytic recycling(GO:0032456) |
0.1 |
0.6 |
GO:0097186 |
amelogenesis(GO:0097186) |
0.1 |
0.4 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
0.1 |
2.1 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 |
0.9 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 |
0.5 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
0.1 |
2.5 |
GO:0030968 |
endoplasmic reticulum unfolded protein response(GO:0030968) |
0.1 |
3.3 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 |
0.2 |
GO:0045359 |
positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.1 |
0.3 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
0.0 |
0.9 |
GO:0022617 |
extracellular matrix disassembly(GO:0022617) |
0.0 |
0.1 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
0.0 |
1.6 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
0.0 |
0.7 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 |
0.2 |
GO:0042795 |
snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 |
0.7 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
0.0 |
1.3 |
GO:1905037 |
autophagosome organization(GO:1905037) |
0.0 |
1.1 |
GO:0006821 |
chloride transport(GO:0006821) |
0.0 |
0.3 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
0.0 |
2.3 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
0.0 |
0.3 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
0.0 |
1.4 |
GO:0030593 |
neutrophil chemotaxis(GO:0030593) |
0.0 |
0.6 |
GO:0032964 |
collagen biosynthetic process(GO:0032964) |
0.0 |
1.1 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
0.0 |
0.0 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.0 |
0.1 |
GO:0021548 |
pons development(GO:0021548) cochlear nucleus development(GO:0021747) |
0.0 |
0.9 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
0.0 |
0.2 |
GO:0050855 |
regulation of B cell receptor signaling pathway(GO:0050855) positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.0 |
0.1 |
GO:0032958 |
inositol phosphate biosynthetic process(GO:0032958) |
0.0 |
0.4 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 |
1.2 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
0.0 |
0.3 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 |
0.0 |
GO:0097484 |
dendrite extension(GO:0097484) |
0.0 |
0.2 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
0.0 |
0.8 |
GO:1902652 |
cholesterol metabolic process(GO:0008203) secondary alcohol metabolic process(GO:1902652) |
0.0 |
0.2 |
GO:0043267 |
negative regulation of potassium ion transport(GO:0043267) |
0.0 |
2.3 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
0.0 |
0.4 |
GO:0006152 |
purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.0 |
1.4 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
0.0 |
0.6 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
0.0 |
0.4 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
0.0 |
0.1 |
GO:0098661 |
inorganic anion transmembrane transport(GO:0098661) |
0.0 |
0.4 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 |
0.3 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
0.0 |
0.2 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 |
0.4 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
0.0 |
0.0 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
0.0 |
0.1 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
0.0 |
0.0 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 |
0.1 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
0.0 |
0.2 |
GO:0060749 |
mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 |
0.0 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
0.0 |
0.2 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
0.0 |
0.3 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
0.0 |
0.5 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
0.0 |
0.2 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
0.0 |
0.3 |
GO:0046928 |
regulation of neurotransmitter secretion(GO:0046928) |
0.0 |
0.2 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
0.0 |
0.8 |
GO:0015807 |
L-amino acid transport(GO:0015807) |
0.0 |
0.1 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 |
0.4 |
GO:0034644 |
cellular response to UV(GO:0034644) |
0.0 |
1.5 |
GO:0098656 |
anion transmembrane transport(GO:0098656) |
0.0 |
0.1 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
0.0 |
0.2 |
GO:0061014 |
positive regulation of mRNA catabolic process(GO:0061014) |
0.0 |
0.3 |
GO:0007143 |
female meiotic division(GO:0007143) |
0.0 |
0.4 |
GO:0010828 |
positive regulation of glucose transport(GO:0010828) positive regulation of glucose import(GO:0046326) |
0.0 |
0.4 |
GO:0034063 |
stress granule assembly(GO:0034063) |
0.0 |
1.1 |
GO:0006643 |
membrane lipid metabolic process(GO:0006643) |
0.0 |
0.4 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
0.0 |
0.4 |
GO:0051056 |
regulation of small GTPase mediated signal transduction(GO:0051056) |
0.0 |
1.1 |
GO:0007605 |
sensory perception of sound(GO:0007605) |
0.0 |
0.3 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
0.0 |
0.0 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.0 |
0.5 |
GO:0030512 |
negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.0 |
0.0 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
0.0 |
0.6 |
GO:0044272 |
sulfur compound biosynthetic process(GO:0044272) |